SCHEDULE: Ameriprise Financial Discloses NPK International Stake
Beneficial Ownership Report
Ameriprise Financial, Inc. and its affiliates reported beneficial ownership of 6.2% of NPK International Inc.'s common stock as of September 30, 2025.
Summary
- Ameriprise Financial, Inc. and its affiliated entities have filed an Amendment No. 8 to Schedule 13G regarding their beneficial ownership in NPK International Inc.
- As of September 30, 2025, Ameriprise Financial, Inc. beneficially owns 5,247,637 shares of NPK International Inc. common stock, representing 6.2% of the class.
- Ameriprise Financial, Inc. holds shared voting power over 5,243,010 shares and shared dispositive power over 5,247,637 shares.
- Several UK-based Threadneedle and TAM UK entities, which are subsidiaries of Ameriprise, each report beneficial ownership of 4,864,300 shares, representing 5.8% of the class, with shared voting and dispositive power over these shares.
- Ameriprise Financial, Inc., as the parent company, is deemed to beneficially own the shares reported by its subsidiaries, and each Ameriprise Entity disclaims beneficial ownership of shares reported on this Schedule.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing (Schedule 13G Amendment) disclosing beneficial ownership. It contains factual information about shareholdings and does not inherently convey positive or negative sentiment regarding the company's performance or outlook.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant institutional ownership, confirming a major financial institution's continued stake in NPK International Inc.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event requiring the filing of this statement. |
| 11/14/2025 | Date of signature for the Schedule 13G filing. |
Keywords
NPK International Inc., Ameriprise Financial, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Asset Management, Threadneedle
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.